Mabwell (Shanghai) Bioscience Co., Ltd. (SHA:688062)
19.01
-0.54 (-2.76%)
Nov 17, 2026, 3:00 PM CST
SHA:688062 Revenue
Mabwell (Shanghai) Bioscience had revenue of 308.48M CNY in the quarter ending September 30, 2026, a decrease of -33.61%. This brings the company's total for the last twelve months to 717.80M, up 14.94% year-over-year. In the year 2025, Mabwell (Shanghai) Bioscience had annual revenue of 662.52M with 231.62% growth. That makes Mabwell (Shanghai) Bioscience the 22,146th largest company in the world by revenue and 4,040th in China.
Revenue (ttm)
717.80M
Revenue Growth
+14.94%
P/S Ratio
11.65
Revenue / Employee
541.74K
Employees
1,356
Market Cap
8.27B
Revenue by Geography
- Mainland China 582.13M 87.9%
- Other Regions 80.38M 12.1%
Fiscal year ended Dec 31, 2025 See the full SHA:688062 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 662.52M | 462.73M | 231.62% |
| Dec 31, 2024 | 199.78M | 71.95M | 56.28% |
| Dec 31, 2023 | 127.84M | 100.11M | 361.03% |
| Dec 31, 2022 | 27.73M | 11.50M | 70.88% |
| Dec 31, 2021 | 16.23M | 10.92M | 206.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Chengzhi | 10.74B |
| Pacific Shuanglin Bio-pharmacy | 2.42B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 2.16B |
| Vcanbio Cell & Gene Engineering Corp., | 1.38B |
| Liaoning Chengda Biotechnology | 1.34B |
| Shanghai OPM Biosciences | 822.13M |
| Chongqing Genrix Biopharmaceutical | 800.98M |
| Hualan Biological Vaccine | 697.41M |
Mabwell (Shanghai) Bioscience News
- 20 days ago - Mabwell (Shanghai) Bioscience Quarterly report: Q3 2026 - Filings
- 2 months ago - Mabwell (Shanghai) Bioscience Quarterly report: Q2 2026 - Filings
- 6 months ago - Mabwell (Shanghai) Bioscience Quarterly report: Q1 2026 - Filings
- 7 months ago - Mabwell (Shanghai) Bioscience Annual report: Q4 2025 - Filings